SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Bio-Rad Laboratories Q1 EPS $1.910 Beats $1.610 Estimate, Sales $571.600M Beat $554.890M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $1.910 per share which beat the analyst consensus estimate of $1.610 by 18.63 percent. This is a 15.76 percent increase over earnings of $1.650 per share

Benzinga · 05/06/2020 20:48

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $1.910 per share which beat the analyst consensus estimate of $1.610 by 18.63 percent. This is a 15.76 percent increase over earnings of $1.650 per share from the same period last year. The company reported quarterly sales of $571.600 million which beat the analyst consensus estimate of $554.890 million by 3.01 percent. This is a 3.18 percent increase over sales of $553.979 million the same period last year.